Showing results (641-650 of 1,030) with videos related to
Sort By:
Pageof 103
The Lancet. Respiratory Medicine|December 8, 2019
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluationThomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.The Lancet. Respiratory Medicine|February 13, 2019
Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysisWouter H van Geffen, Dirk-Jan Slebos, Felix J Herth, et al.The Lancet. Respiratory Medicine|February 8, 2018
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?Paul J Wolters, Timothy S Blackwell, Oliver Eickelberg, et al.The Lancet. Respiratory Medicine|January 27, 2018
Oral prednisolone in preschool children with virus-associated wheeze: a prospective, randomised, double-blind, placebo-controlled trialS J Foster, M N Cooper, S Oosterhof, et al.The Lancet. Respiratory Medicine|May 26, 2022
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trialCameron R Wolfe, Kay M Tomashek, Thomas F Patterson, et al.The Lancet. Respiratory Medicine|May 23, 2022
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trialJing-Xin Li, Shi-Po Wu, Xi-Ling Guo, et al.The Lancet. Respiratory Medicine|July 5, 2021
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workersYaniv Lustig, Einav Sapir, Gili Regev-Yochay, et al.The Lancet. Respiratory Medicine|June 28, 2021
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysisWilliam W Busse, Sally E Wenzel, Thomas B Casale, et al.The Lancet. Respiratory Medicine|March 15, 2020
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trialIan D Pavord, Mark Holliday, Helen K Reddel, et al.The Lancet. Respiratory Medicine|September 20, 2020
Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trialDamon P Eisen, Karin Leder, Robyn L Woods, et al.Pageof 103